Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.4B | 10.5B | 10.3B | 10.0B |
Cost of revenue | 4.8B | 4.3B | 4.3B | 4.0B |
Gross profit | 6.7B | 6.2B | 6.0B | 6.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 805.5M | 667.9M | 588.8M | 628.5M |
Other operating expenses | 2.5B | 2.4B | 2.3B | 2.2B |
Operating income | 2.7B | 2.6B | 2.5B | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 84.5M | 9.9M | 52.7M | 63.8M |
Other income expense | — | — | — | — |
Pretax income | 3.6B | 3.3B | 3.4B | 3.4B |
Tax provision | 777.7M | 685.0M | 809.2M | 811.6M |
Net income | 2.9B | 2.6B | 2.6B | 2.6B |
Basic EPS | — | 27.8 | 27.3 | 27.5 |
Diluted EPS | — | 27.8 | 27.3 | 27.5 |
Basic average shares | — | 93.3M | 94.1M | 94.3M |
Diluted average shares | — | 93.3M | 94.1M | 94.3M |
EBITDA | 4.0B | 3.5B | 3.7B | 3.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.3M | 3.2M | 2.9M | 1.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |